Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.45    -0.65 (-3.23%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €111.86b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

Share Buyback Program

19 Dec 2025 07:21

RNS Number : 2789M
Banco Bilbao Vizcaya Argentaria SA
19 December 2025
 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Company"), in compliance with the Spanish Securities Market legislation, hereby proceeds to notify the following:

 

 

INSIDE INFORMATION

 

Further to the notice of inside information of 16 October 2025, with CNMV registration number 2942, BBVA has received the required authorization from the European Central Bank for the buyback and cancellation of own shares of BBVA for a maximum aggregate amount of 3,960 million euros, in one or several tranches and until 8 December 2026 (the "Authorization"). The maximum amount of 3,960 million euros has been fully deducted from BBVA's individual and consolidated common equity tier 1 (CET1) as from the Authorization receipt.

 

Once the Authorization has been obtained, and in exercise of the authority delegated to it by the Annual Shareholders' Meeting of BBVA held on 18 March 2022, the Board of Directors of BBVA, in its meeting held on 18 December 2025, has agreed to carry out a program scheme for the buyback of own shares in accordance with the provisions of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse and Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016 (together the "Regulations"), which will be executed in several tranches, for a maximum aggregate amount of up to 3,960 million euros, aimed at reducing BBVA's share capital (the "Program Scheme"), notwithstanding the possibility to suspend or early terminate the Program Scheme upon the occurrence of circumstances that make it advisable.

 

Likewise, the Board of Directors has agreed, within the scope of the Program Scheme, to carry out a first tranche in accordance with the provisions of the Regulations with a view to reducing the share capital of BBVA (the "First Tranche") and with the terms and conditions detailed below:

Purpose:

To reduce BBVA's share capital by cancelling the shares acquired.

 

Maximum cash amount:

 

The maximum aggregate cash amount will be 1,500,000,000 euros.

Maximum number of shares:

The maximum number of BBVA shares to be acquired will be 557,316,433.

 

Start of the execution:

Execution will start on 22 December 2025.

End of the execution:

The First Tranche will end neither before 6 March 2026 nor later than 7 April 2026[1] and, in any event, when within such period the maximum cash amount is reached or the maximum number of shares is acquired.

 

However, the Company reserves the right to temporarily suspend execution of the First Tranche or end it early in the event of any circumstance that so advises or requires.

 

Trading Venues:

Purchases shall be made on the Spanish electronic trading system - Continuous Market and on the Cboe Europe, Turquoise Europe and Aquis Exchange trading platforms.

 

Manager:

The First Tranche will be executed externally through J.P. Morgan SE, which will decide independently of the Company on the timing of the purchases of BBVA shares.

 

Minimum Number of Shares Per Day

The Manager shall purchase at least 500,000 BBVA shares on each Trading Day (which is not an Excluded Day nor a Disrupted Day[2]), unless the Manager determines that it would not be possible to achieve the Minimum Number of Shares Per Day without breaching the restrictions and limitations under Delegated Regulation (EU) 2016/1052. Any such occurrence shall be duly disclosed in the periodic communications made in accordance with the Regulations, stating the reason why the Minimum Number of Shares Per Day was not purchased.

 

Other conditions:

The own shares will be purchased observing in all cases the conditions and limits established in the Regulations.

 

The share purchase transactions performed, as well as the end or, as the case may be, the temporary suspension of execution of the First Tranche, will be duly communicated in accordance with the Regulations.

 

 

Madrid, 19 December 2025


[1] However, for each "Excluded Day," the execution period may be postponed by one "Trading Day," up to a maximum postponement until 21 April 2026.

 

A "Trading Day" means each day on which the Continuous Market is scheduled to be open for trading during normal market hours.

 

An "Excluded Day" means any Trading Day on which: (i) any Trading Venue does not open for the entire regular trading session; or (ii) a suspension or limitation on the trading of BBVA shares is imposed on any Trading Venue for the entire regular trading session; or (iii) the trading price of BBVA shares on any Trading Venue is below their nominal value for the entire regular trading session; or (iv) the Company has suspended the execution of the First Tranche.

 

[2] "Disrupted Day" means any Trading Day on which: (i) any Trading Venue is closed for a substantial part of its regular trading session or closes significantly earlier than its scheduled closing time, or there is a significant disruption to trading on any Trading Venue; or (ii) any Trading Venue imposes a suspension or limitation on the trading of BBVA shares for a substantial part of the regular trading session; or (iii) the trading price of BBVA shares on any Trading Venue is below their nominal value for a substantial part of the regular trading session.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUKABRVWUUARA
Date   Source Headline
28th Mar 20257:25 amRNSAdjunstments on the tender offer to Banco Sabadell
21st Mar 20255:18 pmRNSPrudential Relevance Report - Pillar 3 2024
21st Mar 20254:39 pmRNSResult of AGM
11th Mar 20259:27 amRNSStabilisation Notice - BBVA
17th Feb 20253:27 pmRNSStabilisation Notice-BBVA
17th Feb 20257:56 amRNSStabilisation Notice- BBVA
14th Feb 20255:39 pmRNS2025 AGM Notice and Proposed Resolutions
14th Feb 20255:38 pmRNSApril dividend calendar
12th Feb 20257:00 amRNS2025 Annual General Meeting Call
30th Jan 20257:00 amRNSShareholder remuneration for 2024
30th Jan 20257:00 amRNS4Q24 Quarterly Report
30th Jan 20257:00 amRNS4Q24 Results Press Release
30th Jan 20257:00 amRNS4Q24 Earnings Presentation
28th Jan 20255:07 pmRNSRedemption of preferred securities
22nd Jan 202510:32 amRNSBBVA 4Q24 Quarterly Results
9th Jan 20255:48 pmRNSBBVA offer modification
8th Jan 20257:00 amRNSIssue of preferred securities
27th Dec 20247:00 amRNSForm-8.3 Smith (DS) plc - BBVA SA - Unwind 1
23rd Dec 20245:11 pmRNSForm-8.3 Smith (DS) plc - BBVA SA
11th Dec 20245:44 pmRNSBBVA Minimum Capital Requirements for 2025
4th Dec 20245:04 pmRNSEarly Redemption of Subordinated Notes issuance
12th Nov 20245:48 pmRNSCNMC's Resolution on Commencement of Second Phase
31st Oct 20247:00 amRNS3Q24 Results Press Release
31st Oct 20247:00 amRNS3Q24 Results Report
31st Oct 20247:00 amRNS3Q24 Results Presentation
23rd Oct 202411:15 amRNS3Q24 Earnings Presentation Announcement
1st Oct 20246:29 pmRNSAdjustments to the Offer consideration
26th Sep 20248:51 amRNSPost Stabilisation Notice - BBVA 12NC7 Tier 2
26th Sep 20247:04 amRNSIssue of securities contingently convertible
26th Sep 20247:00 amRNSDividend October 2024
5th Sep 20245:17 pmRNSECB Non-opposition to tender offer for B. Sabadell
3rd Sep 20247:26 amRNSAuthorization from the Prudential Regula Authority
31st Jul 20247:00 amRNS2Q24 Results Report
31st Jul 20247:00 amRNS2Q24 Results Press Release
31st Jul 20247:00 amRNS2Q24 Results Presentation
30th Jul 20245:34 pmRNSOrganizational changes
24th Jul 202410:25 amRNS2Q24 Results Presentation Announcement
5th Jul 202411:31 amRNSResolutions adopted at the 2024 Extraordinary AGM
4th Jun 20246:01 pmRNSIssue of preferred securities contingently conv
31st May 20247:00 amRNSBBVA’s Extraordinary General Meeting Call
24th May 20245:52 pmRNSRequest for authorisation voluntary takeover bid
24th May 20245:10 pmRNSBBVAs share capital reduction
9th May 20249:36 amRNSOffer to Banco Sabadell Shareholders Presentation
9th May 20249:33 amRNSPress release offer to Banco Sabadell shareholders
9th May 20249:27 amRNSOffer Announcement Presentation
9th May 20247:00 amRNSVolunt.Tender Offer acquisition shares B.Sabadell
1st May 202412:04 pmRNSLetter to the Board of Directors of Banco Sabadell
30th Apr 20241:37 pmRNSInterest in negotiations with Banco Sabadell
29th Apr 20247:00 amRNS1Q24 Results Presentation
29th Apr 20247:00 amRNS1Q24 Results Press Release

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.